Relic Technologies hires pharma veteran Srivastava as CEO; Iyer exits
The nano-cap company, pivoting to pharma with near-zero revenue, appoints a 25-year pharma sales veteran as whole-time director and CEO, replacing Karthik Iyer.
What's new
- Sachin Srivastava appointed as Whole Time Director and CEO from June 13, 2026.
- Resignation of Executive Director Karthik Iyer accepted, effective same day.
- Srivastava's pharma background aligns with Relic's pivot to pharma and wellness.
Why this matters
For a nano-cap with near-zero revenue and a restructuring underway, this leadership change signals a focused push into pharma. But the lack of quantified financial targets means the move is notable, not a confirmed turnaround.
What we're watching
- First quarterly results under Srivastava's leadership.
- Any update on pharma subsidiary performance or orders.
- Management guidance on revenue breakeven timelines.
The full read
Relic Technologies is betting its future on pharma. The nano-cap, which has near-zero revenue and a market cap of just ₹40 crore, has brought in Sachin Srivastava, a pharma sales veteran with 25 years of experience, as its new Whole Time Director and CEO. Concurrently, Executive Director Karthik Iyer has resigned. The move is the clearest signal yet that Relic intends to execute on its pharma pivot, but it remains a bet without financial proof. The company's restructuring context reduces the element of surprise, and the board meeting lasted only 30 minutes — a routine procedure. The open question is whether Srivastava can convert intent into revenue.
Questions answered
- Who is Sachin Srivastava and why was he appointed?
- Srivastava brings almost 25 years of experience in pharmaceutical sales and marketing. He was appointed as an Additional Director and later as Whole Time Director and CEO to lead Relic's pivot into pharma and wellness businesses.
- Why did Karthik Iyer resign?
- The filing does not specify a reason for Iyer's resignation. It was accepted by the board effective June 13, 2026, the same day Srivastava joined.
- What is Relic Technologies' current financial condition?
- Relic is a nano-cap with a market capitalisation of about ₹40 crore. It has near-zero revenue from operations and a negative PAT growth of 457.5% on a trailing basis, according to our database.
- Is this leadership change a positive sign?
- It signals a strategic commitment to pharma, but the lack of quantified financial impact means it's more a directional move than a concrete turnaround. The market will need to see results before assigning a positive view.
- What does the board meeting duration (30 minutes) indicate?
- A short meeting suggests the agenda was straightforward — likely just the leadership changes and routine approvals. It does not indicate urgency or controversy.